Delivering exceptional cancer care this World Cancer Day

Icon Writers / 02 Feb, 2024

This World Cancer Day 2024, we’re proud to publish our first Impact Report highlighting our contribution and commitment to tackling the growing cancer burden through innovation, research, and comprehensive cancer care for people around the world.

This report shares Icon’s efforts through 2023 as leading providers across cancer care, pharmacy, research and compounding. Delivering more than three million patient interactions across Australia, New Zealand, Singapore, Mainland China, and beyond, together we are making strides in the fight against cancer and providing hope to more people, families and communities.

Through 2023, we opened new cancer centres, introduced leading technologies and treatment techniques, increased our clinical trials capacity, and announced industry partnerships to further turn the dial on cancer care globally.

Icon Group CEO, Mark Middleton said this report reflects the achievements of a global team dedicated to excellence and committed to bringing the best care possible, to as many people as possible, as close to home as possible.

“Icon has a proud history of partnerships and delivering comprehensive cancer care by leveraging an experienced international network of specialists and healthcare professionals,” said Mark.

“Last year, we expanded our services into new regions – our strategic partnership with Nuffield Health will see us deliver treatment in the United Kingdom, and our joint venture with Sunsuria Healthcare will see the team enhance and improve access to cancer care in Southeast Asia.

“Our impact is significant and the next five years will have a continued focus on closing the care gap and bringing world-class healthcare closer to where people live.”

Read the full report below.

View all News


Contact us